Enter assignee name

EPO Patents = 1

Forward Citations = 2

Loading Chart...

5 inventors (with patents filed for the assignee):

Kimberly Drenser (9 out of 11 patents)

Michael T Trese (8 out of 17 patents)

Antonio Capone (7 out of 8 patents)

4. Wendelin Dailey (1 out of 1 patent)

5. Kenneth Mitton (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12485158 - NORRIN INDUCED EXPRESSION OF GENES AND USE THEREOF TO TREAT DISEASE (2025-12-02),

2. 11198714 - Synthetic truncated norrin protein (2021-12-14),

3. 11041863 - Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction (2021-06-22),

4. 10799557 - Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema (2020-10-13),

5. 10703787 - Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema (2020-07-07),

6. 10669321 - Retinal capillary regeneration with synthetic norrin protein (2020-06-02),

7. 10206978 - Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema (2019-02-19),

8. 10202429 - Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema (2019-02-12),

9. 9504649 - Method and compositions for genetic and retinal disease (2016-11-29),

Retinal Solutions LLC is a leading provider of innovative solutions for retina healthcare. We specialize in developing advanced technologies and products to diagnose and treat retinal diseases. Our team of experts is dedicated to improving patient outcomes and transforming the field of retina care. With a focus on cutting-edge research and development, we are committed to delivering high-quality, cost-effective solutions for eye care professionals worldwide.

Profile summary based on public USPTO records.